Patent 11203748 was granted and assigned to Allergan, Inc. on December, 2021 by the United States Patent and Trademark Office.
Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.